Med spa acquisitions: a PE sourcing guide.

Med spa acquisitions have gone from a niche interest to one of the busiest corners of healthcare-adjacent private equity in the space of a few years. Injectables, laser treatments, and membership-based skincare programmes produce the kind of recurring revenue and gross margin that buyers usually have to fight hard for elsewhere. The problem is that most of that buying activity is chasing the same small set of brokered, already-shopped platforms, while thousands of independent, profitable med spas have never had a serious conversation with a private equity buyer.

This guide covers what makes a med spa a good acquisition target, how sourcing them differs from sourcing a medical practice, and the framework for building a pipeline that reaches owners before a banker does.

What counts as a med spa acquisition?

A med spa acquisition is the purchase of a business that delivers non-surgical aesthetic services, typically injectables (neurotoxins and dermal fillers), laser and energy-based treatments, and skincare or wellness services, usually under some form of physician oversight.

That last part is what separates a med spa from a pure day spa and from a dermatology practice. A med spa performs medical-adjacent procedures that require a supervising or medical director physician in most US states, but it is typically owned by a non-physician, often a nurse practitioner or aesthetician-entrepreneur, rather than the treating doctor. That ownership structure is the single most important thing a buyer needs to understand before sourcing in this category, and it is what makes med spas structurally different from the dermatology practices we cover in our dermatology practice acquisitions guide.

Why are med spas becoming one of private equity's favourite roll-up categories?

Med spas are attractive because they combine cash-pay consumer economics with recurring revenue, and the market is still fragmented enough for a real buy-and-build strategy to work. Most locations are independently owned, generate healthy EBITDA margins on a membership or package-based revenue model, and rarely require the multi-year regulatory approval cycles that slow down acquisitions in other healthcare verticals.

That fragmentation is exactly the setup private equity looks for. Cherry Bekaert's 2025 private equity report found that add-on acquisitions now make up roughly three-quarters of all buyouts, and med spas are a natural add-on category: a platform can absorb single-location operators quickly and standardise back-office and compliance functions without disrupting the clinical experience clients came for. With S&P Global reporting that PE buyout dry powder remains above $1 trillion, capital is not the constraint. Finding enough good, still-independent operators before a competing platform does is.

How does sourcing a med spa acquisition differ from sourcing a medical practice?

Med spa acquisitions differ from medical practice acquisitions because the ownership, the regulatory exposure, and the referral pattern do not follow the same rules as a physician-owned practice.

The practical takeaway is that most independent med spas are not sitting inside physician referral networks the way a dermatology practice is. Reaching their owners directly, rather than waiting for a broker to circulate a deck, is where the sourcing advantage actually lives.

What makes a med spa an attractive acquisition target?

Not every location is worth pursuing. The strongest med spa acquisition candidates share a specific set of traits.

• Recurring membership or package revenue. Spas that sell monthly membership tiers or prepaid treatment packages have more predictable revenue than pure walk-in, procedure-by-procedure businesses.
• Injector retention and productivity. A spa's revenue is only as durable as its injectors and estheticians. High turnover among core clinical staff is one of the fastest ways a promising deal falls apart post-close.
• Clean medical director and compliance structure. A spa with a properly documented medical director agreement, standing orders, and protocol library is far easier to fold into a platform than one operating informally.
• Multiple, repeatable revenue lines. Injectables, body contouring, laser hair removal, and skincare retail each add a layer of resilience if consumer demand shifts within any one category.
• Real estate and lease flexibility. Spas in strong retail or medical-adjacent locations with assignable, reasonably priced leases are easier to integrate into a multi-site rollout.

How do you build a sourcing programme for med spa acquisitions?

A systematic approach to med spa acquisitions looks like this:

1. 1. Define your platform thesis first. Decide whether you are building a single-brand rollout, a multi-brand holding structure, or add-ons for an existing platform. This shapes your target profile before you build a single list.
2. 2. Build a target list beyond the brokered market. Most med spa listings that reach a broker have already been shopped. Build a list of independent operators from local business licensing data, franchise directories, and med spa association membership instead.
3. 3. Reach owners directly, and early. Owner-operators in this category are often first-time sellers who have never spoken to a buyer. A direct, respectful outreach programme, not a broker's generic teaser, is usually the first serious conversation they have about a transaction.
4. 4. Screen for medical director and compliance structure before pricing. Confirm the medical director relationship, standing orders, and state-specific corporate practice of medicine exposure early.
5. 5. Assess injector and staff retention risk directly with the owner. Ask who the top-producing injectors are, how long they have been with the practice, and whether they hold any stake that would be disrupted by a sale.
6. 6. Move quickly once interest is confirmed. Independent spa owners rarely run a formal process. A buyer who is organised and fast to follow up usually wins over one still building an internal thesis.

For the broader mechanics of building a platform through repeat acquisitions, see our guide on add-on acquisitions and buy-and-build sourcing.

What are the biggest risks in med spa acquisitions?

The biggest risks in med spa acquisitions are regulatory, not financial. Corporate practice of medicine rules, which restrict non-physicians from owning a medical practice in many US states, mean the ownership and management structure of a target spa needs careful legal review before any letter of intent. A spa that looks clean on paper can still be operating in a legal grey area if its medical director arrangement is informal.

The second major risk is key-person dependency on injectors rather than the owner. In a med spa, the clinical talent often drives repeat business more than the founder does. Losing a top injector shortly after close can meaningfully change the economics of a deal that looked strong at signing.

Conclusion

Med spa acquisitions reward buyers who treat sourcing as a direct-relationship problem rather than a deal-marketplace problem. The category has real tailwinds, real margins, and real roll-up potential, but the operators worth buying are mostly not for sale yet in any formal sense. Building a programme that reaches them before a broker does, and screening rigorously for medical director and injector risk once you are in a conversation, is what separates a platform that compounds from one that overpays for a brokered auction. See how we build outreach programmes for private equity buyers or explore our approach to private equity origination.

Key Terms Glossary

Frequently asked questions